Top

The Journal of Headache and Pain

Published in:

Open Access 01-12-2018 | Short report

Fibromyalgia in migraine: a retrospective cohort study

Authors: Mark Whealy, Sanjeev Nanda, Ann Vincent, Jay Mandrekar, F. Michael Cutrer

Published in: The Journal of Headache and Pain | Issue 1/2018

Abstract

Background

Migraine is a common and disabling disorder. Fibromyalgia has been shown to be commonly comorbid in patients with migraine and can intensify disability. The aim of this study was to determine if patients with co-morbid fibromyalgia and migraine report more depressive symptoms, have more headache related disability, or report higher intensity of headache as compared to patients with migraine only. Cases of comorbid fibromyalgia and migraine were identified using a prospectively maintained headache database at Mayo Clinic Rochester. One-hundred and fifty seven cases and 471 controls were identified using this database and the Mayo Clinic electronic medical record.

Findings

Depressive symptoms as assessed by PHQ-9, intensity of headache, and migraine related disability as assessed by MIDAS were primary measures used to compare migraine patients with comorbid fibromyalgia versus those without. Patients with comorbid fibromyalgia reported significantly higher PHQ-9 scores (OR 1.08, p < .0001) and headache intensity scores (OR 1.149, p = .007). There was no significant difference in migraine related disability (OR 1.002, p = .075). Patients with fibromyalgia were more likely to score in a higher category of depression severity (OR 1.467, p < .0001) and more likely to score in a higher category of migraine related disability (OR 1.23, p = .004).

Conclusion

Patients with comorbid fibromyalgia and migraine report more depressive symptoms, higher headache intensity, and are more likely to have severe headache related disability as compared to controls without fibromyalgia. Clinicians who care for patients with migraine may consider screening for comorbid fibromyalgia particularly in patients with moderate to severe depressive symptoms, high headache intensity and/or high headache related disability. This is the first matched study to look at these characterisitcs, and it replicates previous findings from unmatched studies.

Ifergane G, Buskila D, Simiseshvely N, Zeev K, Cohen H (2006) Prevalence of fibromyalgia syndrome in migraine patients. Cephalalgia 26:451–456. https://doi.org/10.1111/j.1468-2982.2005.01060.x CrossRefPubMed

Kucuksen S, Genc E, Yilmaz H, Salli A, Gezer IA, Karahan AY, Ugurlu H (2013) The prevalence of fibromyalgia and its relation with headache characteristics in episodic migraine. Clin Rheumatol 32:983–990. https://doi.org/10.1007/s10067-013-2218-2 CrossRefPubMed

Marcus DA, Bhowmick A (2013) Fibromyalgia comorbidity in a community sample of adults with migraine. Clin Rheumatol 32:1553–1556. https://doi.org/10.1007/s10067-013-2310-7 CrossRefPubMed

Peres MF, Young WB, Kaup AO, Zukerman E, Silberstein SD (2001) Fibromyalgia is common in patients with transformed migraine. Neurology 57:1326–1328. https://doi.org/10.1212/WNL.57.7.1326 CrossRefPubMed

de Tommaso M, Sardaro M, Serpino C, Costantini F, Vecchio E, Prudenzano MP, Lamberti P, Livrea P (2009) Fibromyalgia comorbidity in primary headaches. Cephalalgia 29:453–464. https://doi.org/10.1111/j.1468-2982.2008.01754.x CrossRefPubMed

de Tommaso M, Federici A, Serpino C, Vecchio E, Franco G, Sardaro M, Delussi M, Livrea P (2011) Clinical features of headache patients with fibromyalgia comorbidity. J Headache Pain 12:629–638. https://doi.org/10.1007/s10194-011-0377-6 CrossRefPubMedPubMedCentral

Fitzcharles M, Yunus M (2012) The clinical concept of fibromyalgia as a changing paradigm in the past 20 years. Pain Research and Treatment 2012:184835. https://doi.org/10.1155/2012/184835 CrossRefPubMed

Cutrer FM (2007) Electronic diaries and charts in a headache Clinic in Headache Clinics: organization, patients and treatment. In: Jensen R, Diener H, Olesen J (eds) Frontiers of headache research, 9th edn. Oxford Univ. Press, West Sussex

Headache Classification Committee of the International Headache Society (IHS) (2013) The international classification of headache disorders, 3rd edition (beta version). Cephalalgia 33:629–808CrossRef

10.

Wolfe F, Clauw DJ, Fitzcharles MA et al (2010) The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 62:600–610CrossRef

11.

Stewart WF, Lipton RB, Whyte J, Dowson A, Kolodner K, Liberman JN, Sawyer J (1999) An international study to assess reliability of the migraine disability assessment (MIDAS) score. Neurology 53:988–994CrossRefPubMed

12.

Kroenke K, Spitzer RL, Williams JB (2001) The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 16:606–613CrossRefPubMedPubMedCentral

13.

Cho SJ, Sohn JH, Bae JS, Chu MK (2017) Fibromyalgia among patients with chronic migraine and chronic tension-type headache: a multicenter prospective cross-sectional study. Headache 57(10):1583–1592CrossRefPubMed

14.

Vij B, Whipple MO, Tepper SJ, Mohabbat AB, Stillman M, Vincent A (2015) Frequency of migraine headaches in patients with fibromyalgia. Headache 55:860–865. https://doi.org/10.1111/head.12590 CrossRefPubMed

15.

Marcus DA, Bernstein C, Rudy TE (2005) Fibromyalgia and headache: an epidemiological study supporting migraine as part of the fibromyalgia syndrome. Clin Rheumatol 24:595–601. https://doi.org/10.1007/s10067-005-1121-x CrossRefPubMed

Title: Fibromyalgia in migraine: a retrospective cohort study
Authors: Mark Whealy
Sanjeev Nanda
Ann Vincent
Jay Mandrekar
F. Michael Cutrer
Publication date: 01-12-2018
Publisher: Springer Milan
Published in: The Journal of Headache and Pain / Issue 1/2018
Print ISSN: 1129-2369
Electronic ISSN: 1129-2377
DOI: https://doi.org/10.1186/s10194-018-0892-9

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Fibromyalgia in migraine: a retrospective cohort study

Abstract

Background

Findings

Conclusion

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Findings

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2018

Sustained onabotulinumtoxinA therapeutic benefits in patients with chronic migraine over 3 years of treatment

Transport of the pituitary adenylate cyclase-activating polypeptide across the blood-brain barrier: implications for migraine

Treatment of disabling headache with greater occipital nerve injections in a large population of childhood and adolescent patients: a service evaluation

The role of personality, disability and physical activity in the development of medication-overuse headache: a prospective observational study

Medication-overuse headache: a widely recognized entity amidst ongoing debate

The validation of the Hungarian version of the ID-migraine questionnaire